20 April 2004
Chondrosarcoma – the second neoplasm in a 16-year-old girl previously treated for Wilms tumor
Katarzyna Sznurkowska , Stefan Popadiuk , Maria Korzon , Mariola RutkowskaCase Rep Clin Pract Rev 2004; 5(null):264-268 :: ID: 12274
Abstract
Background: The incidence of second malignancies seems to be a significant problem, increasing with the progress of oncology. The main factors causing the development of second neoplasms seem to
be chemotherapy and radiotherapy , but the endogenous factors that lead to the first and then second malignancy also play an important role. The most important therapeutic agent that causes second neoplasms is radiotherapy. It was applied in the treatment of almost all patients suffering from second neoplasms after the treatment of Wilms tumor. Second malignancies in the radiation field develop slowly - the average period of their incidence is 12 years.They are usually carcinomas, or bone and soft tissue sarcomas.Case Report: We present the case of a 16-year-old girl, who had undergone treatment of a Wilms tumor in childhood and developed second malignancy in the radiation field.The tumor proliferated in the hip bone infiltrating the vertebral column and inferior vena cava. Although the patient remained under oncological control, the second malignancy was diagnosed at an advanced clinical stage. Effective treatment was impossible because the tumor was inoperable and resistant to chemotherapy.Conclusions: Second malignancies are a rare, but very significant late effect of oncological treatment. Patients who were treated because of malignancies in childhood must be under oncologist’s control throughout the whole life. Patients after radiotherapy in the treatment of Wilms tumor require precise imaging studiesof bones situated in the radiation field.
Keywords: Wilms tumor second malinancy, Chondrosarcoma, children
475
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.949976
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950290
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950607
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950985
Most Viewed Current Articles
07 Dec 2021 : Case report
17,691,734
DOI :10.12659/AJCR.934347
Am J Case Rep 2021; 22:e934347
06 Dec 2021 : Case report
164,491
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
21 Jun 2024 : Case report
113,090
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
59,175
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133






